0719.HK Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 май 2024 @ 11:08):

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products...

Stats
Объем за сегодня	508 000
Средний объем	1.16M
Рыночная капитализация	9.43B
EPS	HKD0.180 ( 2023-09-30 )
Last Dividend	HKD0.219 ( 2023-07-07 )
Next Dividend	HKD0 ( N/A )
P/E	7.06
ATR14	HKD0.0200 (0.37%)

Объем Корреляция

Длинно: -0.01 (neutral)

Кратко: 0.27 (neutral)

Signal:(46.582) Neutral

Shandong Xinhua Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Shandong Xinhua Корреляция - Валюта/Сырье

-0.10
( neutral )

-0.11
( neutral )

0.00
( neutral )

-0.12
( neutral )

0.05
( neutral )

0.07
( neutral )

Shandong Xinhua Финансовые показатели

Annual	2023
Выручка:	HKD8.10B
Валовая прибыль:	HKD2.39B (29.52 %)
EPS:	HKD0.740

FY	2023
Выручка:	HKD8.10B
Валовая прибыль:	HKD2.39B (29.52 %)
EPS:	HKD0.740

FY	2022
Выручка:	HKD7.50B
Валовая прибыль:	HKD2.04B (27.15 %)
EPS:	HKD0.620

FY	2021
Выручка:	HKD6.56B
Валовая прибыль:	HKD1.77B (27.04 %)
EPS:	HKD0.560

Financial Reports:

No articles found.

Shandong Xinhua Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.176 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.219 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Shandong Xinhua Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.81 - Stable (3.83%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0308	2000-05-10
Last Dividend	HKD0.219	2023-07-07
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	HKD1.419	--
Avg. Dividend % Per Year	0.00%	--
Score	3.36	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.81
Div. Directional Score	8.77	--

Next Divdend (Est)
(2024-07-29)

HKD0.240 Estimate 3.09 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3393.HK	Ex Dividend Knight	2023-05-18	Annually	0.00%
1587.HK	Ex Dividend Junior	2023-05-23	Annually	0.00%
0626.HK	Ex Dividend Knight	2023-07-13	Semi-Annually	0.00%
9928.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
2177.HK	Ex Dividend Junior	2023-09-12	Sporadic	0.00%
1171.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
0239.HK	Ex Dividend Knight	2023-09-29	Semi-Annually	0.00%
3888.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
1739.HK	No Dividend Player	2023-09-05	Sporadic	0.00%
0777.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0613	1.500	8.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0575	1.200	8.08	9.70	[0 - 0.3]
returnOnEquityTTM	0.107	1.500	9.92	10.00	[0.1 - 1]
payoutRatioTTM	0.356	-1.000	6.44	-6.44	[0 - 1]
currentRatioTTM	1.425	0.800	7.87	6.30	[1 - 3]
quickRatioTTM	0.916	0.800	9.32	7.46	[0.8 - 2.5]
cashRatioTTM	0.378	1.500	9.01	10.00	[0.2 - 2]
debtRatioTTM	0.155	-1.500	7.41	-10.00	[0 - 0.6]
interestCoverageTTM	13.47	1.000	6.12	6.12	[3 - 30]
operatingCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.245	2.00	9.88	10.00	[0 - 20]
debtEquityRatioTTM	0.276	-1.500	8.90	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.283	1.000	8.62	8.62	[0.2 - 0.8]
operatingProfitMarginTTM	0.0654	1.000	-0.691	-0.691	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.370	1.000	9.05	9.05	[0.2 - 2]
assetTurnoverTTM	0.937	0.800	7.09	5.67	[0.5 - 2]
Total Score				12.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.03	1.000	9.39	0	[1 - 100]
returnOnEquityTTM	0.107	2.50	9.95	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.245	2.00	9.92	10.00	[0 - 30]
dividendYielPercentageTTM	4.32	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
payoutRatioTTM	0.356	1.500	6.44	-6.44	[0 - 1]
pegRatioTTM	-1.291	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0614	1.000	-0.966	0	[0.1 - 0.5]
Total Score				4.81

Shandong Xinhua

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.